These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9922029)

  • 1. Intracellular interleukin-4 profiles during high-dose intravenous immunoglobulin treatment of therapy-resistant atopic dermatitis.
    Jolles S; Hughes J; Rustin M
    J Am Acad Dermatol; 1999 Jan; 40(1):121-3. PubMed ID: 9922029
    [No Abstract]   [Full Text] [Related]  

  • 2. A review of high-dose intravenous immunoglobulin treatment for atopic dermatitis.
    Jolles S
    Clin Exp Dermatol; 2002 Jan; 27(1):3-7. PubMed ID: 11952659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous immune globulin (i.v.IG) therapy in steroid-resistant atopic dermatitis.
    Noh G; Lee KY
    J Korean Med Sci; 1999 Feb; 14(1):63-8. PubMed ID: 10102526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High dose intravenous immunoglobulin in atopic dermatitis and hyper-IgE syndrome.
    Wakim M; Alazard M; Yajima A; Speights D; Saxon A; Stiehm ER
    Ann Allergy Asthma Immunol; 1998 Aug; 81(2):153-8. PubMed ID: 9723561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjunctive high-dose intravenous immunoglobulin treatment for resistant atopic dermatitis: efficacy and effects on intracellular cytokine levels and CD4 counts.
    Jolles S; Sewell C; Webster D; Ryan A; Heelan B; Waite A; Rustin M
    Acta Derm Venereol; 2003; 83(6):433-7. PubMed ID: 14690338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High dose gammaglobulin treatment for atopic dermatitis.
    Kimata H
    Arch Dis Child; 1994 Apr; 70(4):335-6. PubMed ID: 8185369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunomodulation in the treatment of atopic dermatitis].
    Jílek D; Král V; Duchková H; Richter J
    Cas Lek Cesk; 1998 Jun; 137(13):397-9. PubMed ID: 9748732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atopic prurigo nodularis responds to intravenous immunoglobulins.
    Feldmeyer L; Werner S; Kamarashev J; French LE; Hofbauer GF
    Br J Dermatol; 2012 Feb; 166(2):461-2. PubMed ID: 21910702
    [No Abstract]   [Full Text] [Related]  

  • 9. Intravenous immunoglobulin therapy for the treatment of severe atopic dermatitis.
    Lamb SR; Rademaker M
    Expert Opin Pharmacother; 2001 Jan; 2(1):67-74. PubMed ID: 11336569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of interferon-gamma and interleukin-4 on IgE production in B lymphocytes of patients with atopic dermatitis. A possible criterion for selection of patients for interferon therapy.
    Gruner S; Liebenthal C; Heusser C; Brinkmann V; Zwirner A; Reinicke C; Harnack K; Sönnichsen N; Volk HD
    Acta Derm Venereol; 1991; 71(6):484-7. PubMed ID: 1685830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined therapy with low-dose omalizumab and intravenous immunoglobulin for severe atopic dermatitis. Report of four cases.
    Toledo F; Silvestre JF; Muñoz C
    J Eur Acad Dermatol Venereol; 2012 Oct; 26(10):1325-7. PubMed ID: 22050044
    [No Abstract]   [Full Text] [Related]  

  • 12. Dupilumab utility in difficult-to-treat asthma.
    M Walsh G
    Immunotherapy; 2019 Mar; 11(4):261-264. PubMed ID: 30678554
    [No Abstract]   [Full Text] [Related]  

  • 13. Importance of trial design in studies using high-dose intravenous immunoglobulin.
    Jolles S; Hughes J
    Br J Dermatol; 2003 Jun; 148(6):1284-5; author reply 1285-6. PubMed ID: 12828775
    [No Abstract]   [Full Text] [Related]  

  • 14. A randomized controlled evaluator-blinded trial of intravenous immunoglobulin in adults with severe atopic dermatitis.
    Paul C; Lahfa M; Bachelez H; Chevret S; Dubertret L
    Br J Dermatol; 2002 Sep; 147(3):518-22. PubMed ID: 12207594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes of serum levels of interleukin-2, intercellular adhesion molecule-1, endothelial leukocyte adhesion molecule-1 and Th1 and Th2 cell in severe atopic dermatitis after intravenous immunoglobulin therapy.
    Huang JL; Lee WY; Chen LC; Kuo ML; Hsieh KH
    Ann Allergy Asthma Immunol; 2000 Mar; 84(3):345-52. PubMed ID: 10752921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The treatment of atopic dermatitis with adjunctive high-dose intravenous immunoglobulin: a report of three patients and review of the literature.
    Jolles S; Hughes J; Rustin M
    Br J Dermatol; 2000 Mar; 142(3):551-4. PubMed ID: 10735971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cells and T cell-derived cytokines as pathogenic factors in the nonallergic form of atopic dermatitis.
    Akdis CA; Akdis M; Simon D; Dibbert B; Weber M; Gratzl S; Kreyden O; Disch R; Wüthrich B; Blaser K; Simon HU
    J Invest Dermatol; 1999 Oct; 113(4):628-34. PubMed ID: 10504452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical approach to the patient with refractory atopic dermatitis.
    Izadi N; Leung DYM
    Ann Allergy Asthma Immunol; 2018 Jan; 120(1):23-33.e1. PubMed ID: 29273125
    [No Abstract]   [Full Text] [Related]  

  • 19. Experience with intravenous immunoglobulin in severe childhood atopic dermatitis.
    Ozen A; Baris S; Karakoc Aydiner E; Yucelten D; Nadir Bahceciler N
    Allergol Immunopathol (Madr); 2012; 40(2):131-3. PubMed ID: 21855202
    [No Abstract]   [Full Text] [Related]  

  • 20. Black currant seed oil supplementation of mothers enhances IFN-γ and suppresses IL-4 production in breast milk.
    Linnamaa P; Nieminen K; Koulu L; Tuomasjukka S; Kallio H; Yang B; Tahvonen R; Savolainen J
    Pediatr Allergy Immunol; 2013 Sep; 24(6):562-6. PubMed ID: 23980846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.